Related Experiment Video
Updated: Sep 17, 2025

12:27
Modified Laparoscopic Anatomic Hepatectomy: Two-Surgeon Technique Combined with the Simple Extracorporeal Pringle Maneuver
Published on: June 16, 2023
3.1K
Laparoscopic liver parenchymal transection using CUSA versus harmonic scalpel: a protocol for a prospective
Bin Liang1, Yufu Peng1, Wugui Yang1
1Division of Liver Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China.
Therapeutic Advances in Gastroenterology
|June 30, 2025
Summary
This randomized controlled trial will compare the harmonic scalpel (HS) and cavitron ultrasonic surgical aspirator (CUSA) for deep liver parenchymal transection during laparoscopic liver resection. The study will assess safety and efficiency to guide device selection.
Area of Science:
- Hepatobiliary Surgery
- Minimally Invasive Surgery
- Surgical Technology Evaluation
Background:
- Harmonic scalpel (HS) and cavitron ultrasonic surgical aspirator (CUSA) are key techniques for liver parenchymal transection (LPT).
- Current guidelines recommend HS for superficial LPT and CUSA for deep LPT in laparoscopic liver resection (LLR).
- The efficacy and safety of using HS for deep LPT in LLR are not well-established.
Purpose of the Study:
- To investigate the feasibility, safety, and efficiency of HS for deep LPT in LLR.
- To compare HS with CUSA for deep LPT in LLR.
- To provide clinical evidence for optimal LPT device selection in LLR.
Main Methods:
- A randomized controlled trial (RCT) protocol for LLR patients.
- Participants will be randomized to either the HS group or the CUSA group.
- Primary outcome: intraoperative blood loss. Secondary outcomes include operative time, conversion rate, and postoperative outcomes.
Main Results:
- This section is not applicable as the abstract describes a study protocol, not results.
- The study is designed to collect data on intraoperative blood loss, transection velocity, operative time, and patient recovery.
- Subgroup analysis will be performed for patients with liver cirrhosis.
Conclusions:
- This RCT aims to clarify the clinical utility of HS for deep LPT in LLR.
- The findings are expected to inform clinical decision-making regarding LPT device selection.
- The study protocol has ethical approval and is registered in the Chinese Clinical Trial Registry.

